BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12383958)

  • 1. GABAergic modulation in the substantia nigra of the striatal dopamine release and of the locomotor activity in rats exposed to helium pressure.
    Balon N; Kriem B; Weiss M; Rostain JC
    Brain Res; 2002 Sep; 948(1-2):82-92. PubMed ID: 12383958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by GABA transmission in the substantia nigra compacta and reticulata of locomotor activity in rats exposed to high pressure.
    Kriem B; Cagniard B; Bouquet C; Rostain JC; Abraini JH
    Neuroreport; 1998 May; 9(7):1343-7. PubMed ID: 9631426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA(A) receptors in the pars compacta and GABA(B) receptors in the pars reticulata of rat substantia nigra modulate the striatal dopamine release.
    Balon N; Kriem B; Weiss M; Rostain JC
    Neurochem Res; 2002 May; 27(5):373-9. PubMed ID: 12064352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indirect presynaptic modulation of striatal dopamine release by GABA(B) receptors in the rat substantia nigra.
    Balon N; Kriem B; Weiss M; Rostain JC
    Neurosci Lett; 2002 May; 325(1):33-6. PubMed ID: 12023061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
    Lavoute C; Weiss M; Rostain JC
    Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra.
    Burke MV; Nocjar C; Sonneborn AJ; McCreary AC; Pehek EA
    J Neurochem; 2014 Nov; 131(4):432-43. PubMed ID: 25073477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential role of GABAA and GABAB receptors in two distinct output stations of the rat striatum: studies on the substantia nigra pars reticulata and the globus pallidus.
    Ikeda H; Kotani A; Koshikawa N; Cools AR
    Neuroscience; 2010 Apr; 167(1):31-9. PubMed ID: 20132872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of NMDA and GABAA receptors in the inhibiting effect of 3 MPa nitrogen on striatal dopamine level.
    Lavoute C; Weiss M; Rostain JC
    Brain Res; 2007 Oct; 1176():37-44. PubMed ID: 17900538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA(B) receptors modulate depolarization-stimulated [³H]glutamate release in slices of the pars reticulata of the rat substantia nigra.
    Cortés H; Paz F; Erlij D; Aceves J; Florán B
    Eur J Pharmacol; 2010 Dec; 649(1-3):161-7. PubMed ID: 20863782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
    Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
    Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
    Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of the glutamate uptake inhibitor L-trans-PDC in the globus pallidus and the substantia nigra, but not in the striatum, attenuates the psychostimulant effect of high helium pressure on locomotor activity in the rat.
    Abraini JH; Kriem B; Rostain JC
    Neurosci Res; 1999 Dec; 35(4):273-9. PubMed ID: 10617318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigral GABAergic mechanisms and EMG activity in rats: differences between pars reticulata and pars compacta.
    Havemann U; Turski L; Schwarz M; Kuschinsky K
    Eur J Pharmacol; 1983 Aug; 92(1-2):49-56. PubMed ID: 6313391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of pallidal and nigral GABA mechanisms in the generation of tremulous jaw movements in rats.
    Finn M; Mayorga AJ; Conlan A; Salamone JD
    Neuroscience; 1997 Sep; 80(2):535-44. PubMed ID: 9284355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GABA(B) receptor agonists reverse akinesia following intranigral or intracerebroventricular injection in the reserpine-treated rat.
    Johnston T; Duty S
    Br J Pharmacol; 2003 Aug; 139(8):1480-6. PubMed ID: 12922935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic modulation of the release of GABA by GABAA receptors in pars compacta and by GABAB receptors in pars reticulata of the rat substantia nigra.
    Floran B; Silva I; Nava C; Aceves J
    Eur J Pharmacol; 1988 Jun; 150(3):277-86. PubMed ID: 2843383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of either non-NMDA receptor agonists or NMDA receptor antagonists into the substantia nigra or the globus pallidus reduces the psychostimulant effect of high helium pressure on locomotor activity in rats.
    Kriem B; Rostain JC; Abraini JH
    Neuroreport; 1999 Dec; 10(18):3777-83. PubMed ID: 10716209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen.
    Santiago M; Machado A; Cano J
    Br J Pharmacol; 1993 Jul; 109(3):814-8. PubMed ID: 7689406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine.
    Pazo JH; Höcht C; Barceló AC; Fillipini B; Lomastro MJ
    Synapse; 2010 Dec; 64(12):905-15. PubMed ID: 20939061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.
    Garcia-Gil L; de Miguel R; Romero J; Perez A; Ramos JA; Fernández-Ruiz JJ
    Neurotoxicol Teratol; 1999; 21(3):277-83. PubMed ID: 10386831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.